Classification of neonatal jaundice
Due to the multitude of causes leading to elevated bilirubin, several classifications exist. The basic division is based on which fraction of bilirubin predominates in the blood.
Globally, jaundice is divided into two groups:
- With unconjugated hyperbilirubinemia (free bilirubin is elevated).
- With conjugated hyperbilirubinemia (conjugated bilirubin is elevated).
Based on their origin, these conditions are divided into physiological (transient) and pathological (e.g., hemolytic disease of the newborn). Transient jaundice and hemolytic disease of the newborn (HDN) absolutely predominate in the structure of morbidity.
Jaundice with unconjugated hyperbilirubinemia
These conditions occur when free bilirubin is produced in excessively large amounts or its conjugation process in the liver is impaired. Main subgroups:
- Transient (physiological) jaundice — a normal process of physiological adaptation.
- Hemolytic jaundice — caused by enhanced erythrocyte destruction. This includes HDN (immune conflict), hereditary erythrocyte defects (membranopathies, enzymopathies, hemoglobinopathies), and acquired hemolysis due to infections or medications.
- Excess erythrocyte volume — polycythemia (blood thickening) or massive hematomas where erythrocytes are destroyed extravascularly.
- Conjugation disorders — problems with bilirubin binding in the absence of hemolysis. These include genetic syndromes, endocrine disorders (hypothyroidism, maternal diabetes), and neonatal hepatitis.
Jaundice with conjugated hyperbilirubinemia
This group is associated with the development of cholestasis syndrome — when the outflow of already conjugated (direct) bilirubin along with bile is impaired. The disruption can be mechanical or functional.
Depending on the level of obstruction, the following are distinguished:
- Extrahepatic biliary obstruction.
- Intrahepatic obstruction.
Features of transient (physiological) jaundice
An increase in free bilirubin levels is observed in absolutely all newborns, but clinically the skin becomes discolored only upon reaching a certain threshold.
Dynamics depend on gestational age:
- In full-term infants, jaundice appears no earlier than the second day of life. The peak intensity and onset of decline are noted over the next 2–3 days, and the skin clears completely by days 7–10.
- In preterm infants, transient jaundice is more frequent and lasts longer. The decline begins significantly later — around the 8th day of life.
Development mechanism (pathogenesis) is related to the anatomical and physiological characteristics of newborns:
- Hyperproduction: a large volume of erythrocytes and their short lifespan lead to the rapid formation of free bilirubin.
- Decreased transport: blood albumin binds bilirubin less effectively, and the liver lacks the specific carrier protein required to deliver bilirubin to hepatocytes.
- Enzyme immaturity: insufficient activity of glucuronyl transferase, which is responsible for converting unconjugated bilirubin into conjugated bilirubin.
- Decreased excretion: the liver is functionally unready to excrete the entire volume.
- Intestinal phase: free bilirubin is actively reabsorbed from the intestine back into the bloodstream.
Class and exam questions
What is the difference between laboratory hyperbilirubinemia and clinical jaundice?
Laboratory elevation of free bilirubin occurs in all newborns and is physiological. Clinical jaundice (skin discoloration) appears only when the bilirubin level exceeds a certain threshold (80–90 µmol/L in full-term infants).
When should physiological jaundice normally resolve in a full-term infant?
In full-term newborns, complete visual resolution of physiological jaundice typically occurs by the 7th–10th day of life.
Why does direct bilirubin increase in cholestasis syndrome?
In cholestasis, bile outflow is impaired (due to intra- or extrahepatic obstruction), so already conjugated (direct) bilirubin cannot be properly excreted and accumulates.
What else to study on this topic
- Pathogenesis of hemolytic disease of the newborn (HDN)
- Hereditary erythrocyte defects (membranopathies, enzymopathies)
- Genetic syndromes associated with impaired bilirubin conjugation
- Causes of intrahepatic and extrahepatic obstruction in cholestasis
- Impact of neonatal hypothyroidism and maternal diabetes mellitus on bilirubin metabolism
Master the entire topic in the Pediatrics course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Neonatal Jaundice" and 3,738 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 71 video lessons on the subject
Other topics in «Chapter 2. Neonatology»
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.